PMSF NAMES ROBBIE BAKER AS CHIEF EXECUTIVE OFFICER
Phelan-McDermid Syndrome Foundation Names Robbie Baker as Chief Executive Officer by: Denise Croden, President, Phelan-McDermid Syndrome FoundationWe are excited to share…
Posts about legislative activities to advocate for those with Phelan-McDermid syndrome
Phelan-McDermid Syndrome Foundation Names Robbie Baker as Chief Executive Officer by: Denise Croden, President, Phelan-McDermid Syndrome FoundationWe are excited to share…
Together We Are Mighty: Attending the 2025 NORD Breakthrough Summit By: Meagan Hutchinson This week, I had the privilege of attending…
This is a companion piece to our podcast episode, which we recommend listening to or viewing before reading! But if you…
With a past annual budget of nearly $50 billion (yes, that’s with a B!), the National Institute of Health (NIH) is…
Chrissy & Alaina speaking at the ground breaking for 1st rest stop in TN by Chrissy HoodWhen a family prepares to…
The new code is Q93.52 and will go into effect October 1, 2023. A years-long dream has been achieved for Phelan-McDermid…
What was the event? PMS mom and PMSF rep Anna Williams participated at an annual Epilepsy Foundation Research Roundtable in Washington…
PMSF Releases the first in a series of Quick Resource Cards by Diane Linnehan, Director of Operations and Jenn Carter, Mom…
by Brooke Turner Jones, Mom to TurnerWe are excited about the prospects of PMS Awareness Day 2023, as it will be…
Dr. Sheng-Nan Qiao at Yale University applied to study the link between brain inflammation and regression (loss of skills) in PMS. The funded project focuses on approaches for reducing neuro-inflammation when modeling Phelan-McDermid syndrome in the laboratory.